We observed that the frequencies of SARS-CoV-2 spike-specific CD4+ and CD8+ T cells were not significantly different between older and younger adults after 2 doses of COVID-19 mRNA vaccine, and that these responses were enhanced similarly by a third vaccine dose regardless of age. The gene discussed is CD8A; the disease is COVID-19.